Literature DB >> 5641961

A 15-year follow-up study of patients treated for carcinoma of the breast.

D Brinkley, J L Haybittle.   

Abstract

Entities:  

Mesh：

Year:  1968        PMID： 5641961     DOI： 10.1259/0007-1285-41-483-215

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  13 in total

1.  The curability of breast cancer.

Authors:  M Baum
Journal:  Br Med J       Date:  1976-02-21

2.  The curability of breast cancer.

Authors:  D Brinkley; J L Haybittle
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

Review 3.  Survivorship in untreated breast cancer patients.

Authors:  Carlos M Galmarini; Olivier Tredan; Felipe C Galmarini
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

4.  The dubious case for conservative operation in operable cancer of the breast.

Authors:  T J Anglem; R E Leber
Journal:  Ann Surg       Date:  1972-11       Impact factor: 12.969

5.  Cancer of the breast. Treatment of the advanced disease.

Authors:  J Hayward
Journal:  Br Med J       Date:  1970-05-23

6.  Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer.

Authors:  John M McLaughlin; Roger T Anderson; Amy K Ferketich; Eric E Seiber; Rajesh Balkrishnan; Electra D Paskett
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

Review 7.  Patterns of metastasis and natural courses of breast carcinoma.

Authors:  Y T Lee
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  The curability of breast cancer.

Authors:  W Duncan; G R Kerr
Journal:  Br Med J       Date:  1976-10-02

9.  Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1981-08-03

10.  Extracellular NM23 Signaling in Breast Cancer: Incommodus Verum.

Authors:  Iain L O Buxton; Nucharee Yokdang
Journal:  Cancers (Basel)       Date:  2011-09       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.